GSK - GlaxoSmithKline plc

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
Currency in GBP. All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue30,821,00030,186,00027,889,00023,923,000
Cost of Revenue9,714,0009,317,0008,907,0008,853,000
Gross Profit21,107,00020,869,00018,982,00015,070,000
Operating Expenses
Research Development3,798,0003,925,0003,550,0003,560,000
Selling General and Administrative9,366,0009,256,0008,852,0009,232,000
Non Recurring----
Others309,000799,0001,292,000-269,000
Total Operating Expenses23,187,00023,297,00022,601,00021,376,000
Operating Income or Loss7,634,0006,889,0005,288,0002,547,000
Income from Continuing Operations
Total Other Income/Expenses Net-2,834,000-3,364,000-3,349,0007,979,000
Earnings Before Interest and Taxes7,634,0006,889,0005,288,0002,547,000
Interest Expense-754,000-720,000-701,000-719,000
Income Before Tax4,800,0003,525,0001,939,00010,526,000
Income Tax Expense754,0001,356,000877,0002,154,000
Minority Interest-688,0003,557,0003,839,0003,764,000
Net Income From Continuing Ops4,046,0002,169,0001,062,0008,372,000
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income3,623,0001,532,000912,0008,422,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares3,623,0001,532,000912,0008,422,000